The aim of this study was to investigate local opioid effects in the inflamed skin of healthy human volunteers. To induce inflammation, the circular tip of a 10-mm diameter probe was heated to 48ºC and applied for 120 s to a site on each forearm of 24 healthy participants. Thirty minutes later, 0.2 mL normal saline was injected subcutaneously into one inflamed site, and the opioid antagonist naloxone hydrochloride (80 µg in 0.2 mL)
Introduction
Opioids are usually administered systemically to control pain. However, opioid receptors are known to be present on cutaneous sensory nerves in rats 19 and humans. 18 The peripheral administration of opioids has been found to produce analgesia without systemic side effects in animals 15 and humans in response to clinical 4, 12 and experimentally induced pain. 7, 14 Peripherally administered opioids produce negligible analgesia in uninflamed tissue but potent analgesia in inflamed tissue. 19 Experimental procedures that do not injure tissue, such as intradermal injection or topical application of low doses of capsaicin, 7, 8 sensitize nociceptors and have been useful models of neurogenic inflammation. However, procedures that damage tissue, such as burning the skin, 16 freezing the skin or pinching the interdigital web, 5, 6 more closely represent inflammatory pain. Experimentally-induced cutaneous burns produce reliable effects on pain sensitivity, the magnitude of which is repeatable within participants. 16 Controlled burns induce thermal hyperalgesia and can also evoke mechanical hyperalgesia, but this appears to require a more severe burn than hyperalgesia to heat. 2 Opioids administered following experimentally-induced burn injury in humans consistently reduce burn-induced hyperalgesia. 9, 14 Such antihyperalgesia appears to be more pronounced for thermal than mechanical stimuli. Koppert et al. 9 examined the effect of peripheral opioids in skin burnt by ultraviolet irradiation. One day after the induction of inflammation, the blood supply to the arm was limited by the inflation of a pressure cuff to ensure that any opioid effect was peripheral. Morphine hydrochloride (4 mg in 40 mL) was then administered intravenously to the burnt site. Morphine reduced thermal Page 4 of 20 pain but not mechanical pain sensitivity, an effect that apparently was mediated by a local mechanism because the concentration of morphine and morphine metabolites in the systemic circulation was insufficient to have induced analgesia centrally. Moiniche, Dahl, and Kehlet 14 investigated the antinociceptive effect of 2 mg morphine injected subcutaneously at a site of thermal injury. Approximately 30 min later, thermal and mechanical pain thresholds were greater at the morphine site than at a burnt site injected with saline. In addition, most participants reported that the morphine-treated site was less sensitive than the saline-treated site.
The antihyperalgesia described in these studies was assumed to be the product of peripheral opioid receptor activation. However, this must remain speculative in the absence of studies demonstrating blockade of antihyperalgesia by an opioid receptor antagonist. Thus, the aim of the present study was to determine whether the opioid receptor antagonist naloxone would block the local antihyperalgesic effect of the muopioid receptor agonist fentanyl in the inflamed skin of healthy volunteers. It was hypothesized that the subcutaneous injection of fentanyl into burnt skin would reduce hyperalgesia to thermal and mechanical stimuli, and that pre-treatment with naloxone would reduce the potency of this antihyperalgesia.
Methods

Participants
Participants were 24 healthy volunteers (nine men and 15 women) whose ages ranged from 17 to 39 yr (median = 25.5 yr). Participants were advised not to drive a car for 6 hours following the procedures, and were reimbursed a small sum of money for their time and travel costs. Exclusion criteria were pregnancy and narcotic addiction, Heat pain thresholds (HPTs) were measured using a heat lamp which directed radiant heat from a halogen globe through a lens and circular aperture (1.1 cm in diameter) onto the skin. Skin temperature was measured by a thermistor, which was positioned under an aluminum shield in the center of the aperture. The arm of the lamp could be adjusted to allow the thermistor to touch the skin lightly without transferring the weight of the lamp. Skin temperature was held at a baseline of 35.6ºC for 10 s and then increased linearly by 0.5ºC/s. In the hand contralateral to the stimulated arm, participants held a button which they were instructed to press when they first felt pain. The lamp switched off when the button was pressed or the temperature reached 47ºC. The HPT estimate was the temperature at which the lamp switched off. Two HPT estimates were Page 6 of 20 conducted at each site, with a third administered if the first two differed by more than 2ºC (14% of trials). For each site, the mean of the 2-3 HPT estimates was recorded.
Heat pain ratings (HPRs) were made in response to the application of the heat lamp at 45ºC for 5 s. Participants rated pain severity using a computerized 10-cm visual analogue scale (VAS), marked only with the endpoints "no pain" and "worst pain ever".
Ratings previously to investigate local opioid effects. 14 The 10 µg dose of fentanyl in 0.2 mL saline was based on extensive pilot studies that established that a smaller dose or a greater injection volume was ineffective in countering hyperalgesia. 17 The 80 µg dose of naloxone was also based on pilot studies. 17 In humans, systemic administration of high doses of naloxone (7.5 and 10 mg) induces hyperalgesia whereas low doses (0.4 and 2 mg) induce analgesia; 10 however, very low doses (40 µg) have no systemic effect. 20 Local injection of naloxone at doses as low as 5 µg in the inflamed rat paw blocks the local antihyperalgesic effect of opioid agonists. 1 Pain sensitivity was measured again at the experimental sites starting 5 min after the fentanyl injections. Total testing duration was approximately 1.75 hr.
All HPT, HPR, and MPR data are displayed as means ± standard error of the mean. Separate 2 (drug: saline pre-treatment, naloxone pre-treatment) x 2 (phase: before and after fentanyl) repeated measures analyses of variance were conducted to investigate changes in HPT, HPR, and MPR after the fentanyl injections. Significant drug x phase interactions were investigated further with paired t-tests, to determine whether the antihyperalgesic effect of fentanyl was greater at the saline-pretreated site than the naloxone-pretreated site. A Bonferroni correction was not necessary for these t-tests because only two sites were compared.
Results
Effect of burn injury on pain sensitivity
As shown in Table 1 , the burn injuries produced moderate hyperalgesia to heat and weak hyperalgesia to mechanical stimulation. In particular, the mean HPT at the burnt sites was lower than the mean HPT at the untreated sites, and the mean HPR and MPR at the burnt sites were greater than the mean HPR and MPR at the untreated sites.
The effect of the burn injury on thermal and mechanical pain sensitivity was consistent across both burnt sites.
Effect of fentanyl on pain sensitivity at sites pre-treated with saline or naloxone
The HPT did not differ significantly between the saline and naloxone sites before the fentanyl injections, but the HPT increased after the fentanyl injections at the site pre- 
Discussion
The main finding of the present study was that local pre-treatment with the opioid antagonist naloxone blocked the antihyperalgesic effects of the mu-opioid agonist fentanyl on HPT and MPR. However, contralateral pre-treatment with naloxone did not block the antihyperalgesic effects of fentanyl. Thus, the antihyperalgesia induced by fentanyl apparently was mediated locally by mu-opioid receptors on peripheral nerves. 18, 19 These findings are consistent with research conducted on non-human species that identified peripheral opioid effects in inflamed and burnt skin. 15, 19 Our procedures did not permit us to ascertain whether the injections of fentanyl also acted centrally to inhibit pain. However, this seems unlikely because hyperalgesia did not decrease significantly at the naloxone-pretreated site after the fentanyl injections.
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We chose to employ a mild burn to avoid tissue damage and blisters that might complicate the interpretation of findings. In contrast, Moiniche et al. 14 heated the skin to 49 o C for 5 minutes, resulting in blisters and second-degree burns. Koppert et al. 9 irradiated the skin with ultraviolet B light and studied the resultant hyperalgesia 24 hours later. To ensure that intravenously administered morphine did not exert any systemic effect, the blood supply to the hyperalgesic limb was blocked for 20 min with a cuff at 250 mm Hg while pain sensitivity was determined. Cuff pressure may have had effects on pain sensitivity that were independent from those of ultraviolet irradiation (e.g., potentiation of hyperalgesia due to accumulation of lactic acid, or attenuation of hyperalgesia due to pressure block of peripheral nerves). Furthermore, the use of morphine in both of these studies complicates the methodology as morphine induces mast cell degranulation and consequent pro-inflammatory effects. One limitation of the present study is that the sample was too small to investigate gender differences in the response to fentanyl. This might be important, because females appear to be more sensitive than males to drugs that act at opioid receptors. 21 Another limitation is that the 2-min application of a 48ºC heat probe produced weak mechanical opioid system is active in healthy humans. Furthermore, this study supports the efficacy of peripherally applied opioids for the relief of localized inflammatory pain. 13 Further clinical studies are needed to investigate the therapeutic effect of subcutaneously administered fentanyl for individuals with painful cutaneous disorders. 
